Clinical and serologic follow-up in patients with neuroborreliosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9818893.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors performed a clinical and serologic follow-up study after 4.2 +/- 1.2 years in 44 patients with clinical signs of neuroborreliosis and specific intrathecal antibody production. All patients had been treated with ceftriaxone 2 g/day for 10 days. Although neurologic deficits decreased significantly, more than half the patients had unspecific complaints resembling a chronic fatigue syndrome and showed persisting positive immunoglobulin M serum titers for Borrelia in the Western blot analysis.
Medical subject headings
- Borrelia burgdorferi Group
- Ceftriaxone
- Lyme Disease
- Nervous System Diseases